Dyslipidemias or dyslipoproteinemias are quantitative changes in total cholesterol
concentration, respective fractions, or triglycerides in the plasma. Evidence supported that …

Icosapent ethyl (IPE) was the first fish oil product the US Food and Drug Administration
(FDA) approved to reduce the risk of atherosclerotic cardiovascular disease (ASCVD) in …

En la actualidad, la obesidad en el niño está mundialmente considerada como una
enfermedad de proporciones epidémicas. En 20 años, se ha incluido de forma duradera …

Dyslipidemia in childhood and adolescence: from screening to... : Current Opinion in
Endocrinology, Diabetes and Obesity Dyslipidemia in childhood and adolescence: from …

Abstract Objective Prader–Willi Syndrome (PWS) is the most common genetic cause of
obesity. Prevention and management of obesity, which represents the main cause of …

Background: The presence of dyslipidemia and behavioral aspects are determinants of
cardiovascular risk, especially in childhood and adolescence. Objective: To verify possible …

Non-alcoholic fatty liver disease (NAFLD) affects almost a quarter of the world's population
and is the most common cause of chronic liver disease in children and adolescents. The …

In evaluating a patient with dyslipidemia the initial step is to decide which particular
lipid/lipoprotein abnormalities need to be evaluated and whether they need treatment …

Adolescents with comparable personal risk factors may have different lipid profiles because
of the school's context. Lipid determinants in adolescents should be considered using a …

Abstract Purpose of Review Combined dyslipidemia (CD), the predominant abnormal lipid
pattern in children and adolescents, is characterized by moderate/severe triglyceride …